128 related articles for article (PubMed ID: 29608546)
21. Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Muszkat M; Matok I
Pharmacotherapy; 2019 Jun; 39(6):690-696. PubMed ID: 30917404
[TBL] [Abstract][Full Text] [Related]
22. Calcium channel blockers and risk of breast cancer: a meta-analysis of 17 observational studies.
Li W; Shi Q; Wang W; Liu J; Li Q; Hou F
PLoS One; 2014; 9(9):e105801. PubMed ID: 25184210
[TBL] [Abstract][Full Text] [Related]
23. Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.
Hicks BM; Busby J; Mills K; O'Neil FA; McIntosh SA; Zhang SD; Liberante FG; Cardwell CR
BMC Cancer; 2020 Aug; 20(1):804. PubMed ID: 32831062
[TBL] [Abstract][Full Text] [Related]
24. Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly.
Bettiol A; Lucenteforte E; Vannacci A; Lombardi N; Onder G; Agabiti N; Vitale C; Trifirò G; Corrao G; Roberto G; Mugelli A; Chinellato A;
Clin Drug Investig; 2017 Dec; 37(12):1165-1174. PubMed ID: 28975522
[TBL] [Abstract][Full Text] [Related]
25. Association between long-term use of calcium channel blockers (CCB) and the risk of breast cancer: a retrospective longitudinal observational study protocol.
Ho C; Ha NT; Youens D; Abhayaratna WP; Bulsara MK; Hughes JD; Mishra G; Pearson SA; Preen DB; Reid CM; Ruiter R; Saunders CM; Stricker BH; van Rooij FJA; Wright C; Moorin R
BMJ Open; 2024 Mar; 14(3):e080982. PubMed ID: 38458796
[TBL] [Abstract][Full Text] [Related]
26. Association Between the Overall Risk of Prostate Cancer and Use of Calcium Channel Blockers: A Systematic Review and Meta-analysis.
Yang H; Yu Y; Hu X; Wang W; Yang X; Liu H; Ren L; Zhang X; Feng X; Liu L
Clin Ther; 2020 Sep; 42(9):1715-1727.e2. PubMed ID: 32807506
[TBL] [Abstract][Full Text] [Related]
27. Relationship between calcium channel blocker class and mortality in dialysis.
Wetmore JB; Mahnken JD; Phadnis MA; Ellerbeck EF; Shireman TI
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1249-58. PubMed ID: 26371369
[TBL] [Abstract][Full Text] [Related]
28. No Association Between Calcium Channel Blockers and Survival in Patients with Cancer: A Systematic Review and Meta-analysis.
Sun H; Zhuang RY; Li T; Zheng YT; Cai WM
Asian Pac J Cancer Prev; 2016; 17(8):3917-21. PubMed ID: 27644639
[TBL] [Abstract][Full Text] [Related]
29. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
[TBL] [Abstract][Full Text] [Related]
30. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.
Wilson LE; D'Aloisio AA; Sandler DP; Taylor JA
Breast Cancer Res; 2016 Jul; 18(1):61. PubMed ID: 27378129
[TBL] [Abstract][Full Text] [Related]
31. A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients.
Wu CL; Wen SH
Medicine (Baltimore); 2016 Aug; 95(32):e4593. PubMed ID: 27512890
[TBL] [Abstract][Full Text] [Related]
32. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
[TBL] [Abstract][Full Text] [Related]
33. Treatment of angina pectoris with calcium antagonists: long-term follow-up.
Behar S
Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():119-24. PubMed ID: 9642485
[TBL] [Abstract][Full Text] [Related]
34. Calcium Channel Blockers and the Risk for Lung Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Glazer M; Muszkat M; Matok I
Ann Pharmacother; 2019 May; 53(5):445-452. PubMed ID: 30442036
[TBL] [Abstract][Full Text] [Related]
35. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
36. B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study.
Dhar I; Svingen GF; Bjørnestad EØ; Ulvik A; Saeed S; Nygård OK
Am J Clin Nutr; 2023 Jul; 118(1):77-84. PubMed ID: 37121550
[TBL] [Abstract][Full Text] [Related]
37. Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1804-7. PubMed ID: 26364159
[TBL] [Abstract][Full Text] [Related]
38. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
39. Cancer risk and mortality in users of calcium channel blockers. A cohort study.
Sørensen HT; Olsen JH; Mellemkjaer L; Marie A; Steffensen FH; McLaughlin JK; Baron JA
Cancer; 2000 Jul; 89(1):165-70. PubMed ID: 10897013
[TBL] [Abstract][Full Text] [Related]
40. Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013).
Hwang D; Kim S; Choi H; Oh IH; Kim BS; Choi HR; Kim SY; Won CW
Circ J; 2016 Oct; 80(11):2336-2342. PubMed ID: 27666598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
